Yearly Archives: 2022
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test
SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central […]
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital
Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at the upcoming Life Sciences Day on the Hill on February 16, 2022, at the Utah State Capital Building. It is expected that the conference, […]
Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators
New Nelson Labs Mark offers transparency and confidence in product testing
IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test
Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has filed a De Novo application with the U.S. Food and Drug Administration (the “FDA”) for its IONIQ ProLung Test™ used for lung cancer. Mr. Jared Bauer, IONIQ Sciences CEO, stated, “Today we submitted our De […]
Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage
Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity
Biomerics Announces Expansion in Costa Rica With New Plant in Cartago
Biomerics inaugurated its second plant in Costa Rica.
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors
Foldax Appoints Scott Huennekens to Board of Directors
Foldax Appoints Scott Huennekens to Board of Directors
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
PolarityTE, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for the evaluation of SkinTE for the treatment of chronic cutaneous ulcers.
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex Test
Co-Diagnostics, Inc. announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its SARAGENE™ Human Papillomavirus High-Risk (HPV-HR) Real-Time PCR test as an in vitro diagnostic (“IVD”)
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
Positive Study Results Published for KidneyIntelXTM in Monitoring Patient Response to New Drug Therapy
